Scientific watch for new therapies

Presentation of our Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies.

Produced by Synergyx Conseils Inc.

This study was carried out with financial support from Takeda, Pfizer and Vertex.

Consult the document

. - 1,53 MB

Documents

We suggest

Recommandations en vue du budget provincial 2017-2018

Mettre en place dans le cadre de la stratégie des SVTS un dialogue permanent entre le secteur des SVTS et le gouvernement afin de contribuer à la stabilité de l’environnem...

Mapping of non-dilutive financing available in Quebec for LSHT companies

Please note that our mapping is updated monthly. The last update was on September 30, 2025. For any suggestions for changes, please write to agouronnec@montreal-invivo.com

Data sheets

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

Documents

We suggest

Briefs and consultations

Recommandations en vue du budget provincial 2017-2018

Studies and analysis

Mapping of non-dilutive financing available in Quebec for LSHT companies

Sommaire exécutif du Plan stratégique sur les maladies rares

Data sheets

Scientific watch for new therapies indicated in the treatment of rare conditions as well as cell and gene technologies

Documents

We suggest

Briefs and consultations

Recommandations en vue du budget provincial 2017-2018

Studies and analysis

Mapping of non-dilutive financing available in Quebec for LSHT companies

Sommaire exécutif du Plan stratégique sur les maladies rares

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters